Accession Number: | 0001367644-20-000084 |
Date: | 2020-05-26 |
Issuer: | EMERGENT BIOSOLUTIONS INC. (EBS) |
Original Submission Date: |
ZOON KATHRYN C
400 PROFESSIONAL DRIVE
GAITHERSBURG, MD 20879
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-05-26 | S | 4,093 | d | $85.10 | 13,489 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | consists of restricted stock units granted under the company's stock incentive plan, as amended and restated. |
f2 | the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by dr. zoon. |
f3 | the price reported is a weighted average sale price. these shares were sold in multiple transactions at prices ranging from $84.14 to $86.28. |